Gene: SENP3
Official Full Name: SUMO specific peptidase 3provided by HGNC
Gene Summary: The reversible posttranslational modification of proteins by the addition of small ubiquitin-like SUMO proteins (see SUMO1; MIM 601912) is required for numerous biologic processes. SUMO-specific proteases, such as SENP3, are responsible for the initial processing of SUMO precursors to generate a C-terminal diglycine motif required for the conjugation reaction. They also have isopeptidase activity for the removal of SUMO from high molecular mass SUMO conjugates (Di Bacco et al., 2006 [PubMed 16738315]).[supplied by OMIM, Jun 2009]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO09668 | SENP3 Knockout cell line (HeLa) | Human | SENP3 | 1:3~1:6 | Negative | Online Inquiry |
KO09669 | SENP3 Knockout cell line (HCT 116) | Human | SENP3 | 1:2~1:4 | Negative | Online Inquiry |
KO09670 | SENP3 Knockout cell line (HEK293) | Human | SENP3 | 1:3~1:6 | Negative | Online Inquiry |
KO09671 | SENP3 Knockout cell line (A549) | Human | SENP3 | 1:3~1:4 | Negative | Online Inquiry |
SENP3 Gene Knockout Cell Lines are genetically engineered cell lines specifically developed to lack the expression of the SENP3 gene, a crucial player in the regulation of SUMO (Small Ubiquitin-like Modifier) conjugation. SENP3 is known to perform the vital function of desumoylating target proteins, thus modulating various cellular processes including proliferation, apoptosis, and response to stress. These knockout cell lines provide researchers with a powerful tool to investigate the consequential changes in cellular behavior that arise specifically from the loss of SENP3 activity.
The mechanism by which SENP3 operates involves the removal of SUMO tags from substrate proteins, thereby influencing their function and stability. By employing SENP3 Gene Knockout Cell Lines, scientists can observe the downstream effects of altered SUMOylation, leading to enhanced understanding of molecular mechanisms underlying numerous biological processes and diseases. This can play a pivotal role in cancer research, neurobiology, and studies involving cellular differentiation, inflammation, and immune response.
Compared to traditional cell lines, these knockout models offer unparalleled specificity and reliability in experiments focused on the SENP3 signaling pathway. They allow for reduced background noise when assessing SENP3-related assays, enabling more precise interpretations of data. Furthermore, these cell lines serve as valuable platforms for drug discovery, particularly for therapeutic agents targeting SUMOylation pathways.
For researchers and clinicians, the value of SENP3 Gene Knockout Cell Lines lies in their ability to streamline experimental design and provide insight into complex biological networks. By employing these advanced tools, users can gain novel insights into cellular functions and contribute to significant advancements in medical research and therapeutic development.
Our company brings extensive expertise in the development of specialized biological products, offering a portfolio designed to facilitate cutting-edge research and innovation. With a commitment to supporting the scientific community, we ensure that our products not only meet the highest standards of quality but also empower researchers in their quest for discovery.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.